DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID ▼ | Gene Name | UniProt ID |
---|---|---|---|---|---|
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | LYPLA1 | 10434 | lysophospholipase 1 | O75608 |
C0600139 | Prostate carcinoma | LYPLA1 | 10434 | lysophospholipase 1 | O75608 |
C0026896 | Myasthenia Gravis | CDIPT | 10423 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | O14735 |
C2930619 | Sex Differentiation Disorders | CDIPT | 10423 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | O14735 |
C0019269 | Hermaphroditism | CDIPT | 10423 | CDP-diacylglycerol--inositol 3-phosphatidyltransferase | O14735 |
C0026764 | Multiple Myeloma | ST3GAL6 | 10402 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | Q9Y274 |
C0038356 | Stomach Neoplasms | ST3GAL6 | 10402 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | Q9Y274 |
C2239176 | Liver carcinoma | ST3GAL6 | 10402 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | Q9Y274 |
C0009402 | Colorectal Carcinoma | ST3GAL6 | 10402 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | Q9Y274 |
C0007097 | Carcinoma | ST3GAL6 | 10402 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | Q9Y274 |
C0027651 | Neoplasms | ST3GAL6 | 10402 | ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | Q9Y274 |
C0400966 | Non-alcoholic Fatty Liver Disease | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0027651 | Neoplasms | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0036341 | Schizophrenia | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C2711227 | Steatohepatitis | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0023890 | Liver Cirrhosis | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0015696 | Fatty Liver, Alcoholic | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0345904 | Malignant neoplasm of liver | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0007114 | Malignant neoplasm of skin | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0268238 | Triglyceride storage disease with ichthyosis | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0011847 | Diabetes | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0011849 | Diabetes Mellitus | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0699885 | Carcinoma of bladder | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0015695 | Fatty Liver | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
C0678222 | Breast Carcinoma | PEMT | 10400 | phosphatidylethanolamine N-methyltransferase | Q9UBM1 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024